Chemistry of Natural Compounds is a premier academic journal dedicated to the intersection of natural products and modern chemistry, published by Springer. Since its inception in 1965, this journal has published innovative research articles, reviews, and discussions that focus on the chemistry and biochemistry of natural compounds, with an emphasis on their applications in various fields including medicine, agriculture, and environmental science. Recognized for its contributions to the scientific community, the journal is indexed in key databases and holds a respectable impact factor that underscores its relevance in the academic landscape. Currently ranked in the Q3 category across multiple disciplines, including Biochemistry, Genetics and Molecular Biology, Chemistry, and Plant Science, it serves as a critical resource for researchers and professionals aiming to deepen their understanding of the complex interactions between natural compounds and biological systems. While not an open-access journal, Chemistry of Natural Compounds provides valuable insights and essential findings that can aid in advancing both theoretical and applied sciences for researchers, students, and industry practitioners alike.

Journal of Pharmacy & Pharmacognosy Research, published by JOURNAL PHARMACY & PHARMACOGNOSY RESEARCH-JPPRES, is a prominent open-access journal established in 2013, headquartered in Antofagasta, Chile. With a focus on the fields of Complementary and Alternative Medicine, Drug Discovery, Pharmaceutical Science, Pharmacology, and Pharmacy, this journal is recognized for its commitment to advancing research and disseminating knowledge within these important areas. With a current impact factor that reflects its academic rigor and relevance, the journal has achieved substantial recognition, evident by its Q2 and Q3 quartile rankings in multiple categories, indicating its growing influence on the scientific community. The Scopus rankings further highlight its standing in pharmacy and pharmacological disciplines, providing a valuable platform for researchers, professionals, and students to share their findings and insights. With its open access model, the journal ensures that high-quality research is available to a global audience, paving the way for collaborative advancements in pharmaceutical sciences.

Natural Products and Bioprospecting is a prestigious academic journal published by SPRINGERNATURE, dedicated to advancing research in the fields of analytical chemistry, biochemistry, plant science, organic chemistry, and pharmacology. With an impact factor that positions it within the top quartiles across multiple categories, this journal serves as a crucial platform for disseminating groundbreaking findings and innovative methodologies focusing on the potential of natural products. Since adopting its Open Access model in 2011, it has broadened its reach, allowing global accessibility to cutting-edge research. The journal, based in Singapore, aims to foster interdisciplinary collaboration and encourages submissions that explore the intricate relationships between natural products and their applications in food science, toxicology, and pharmacology. Its well-respected status is further highlighted by impressive Scopus ranks and a growing H-index, reinforcing its significance in the scientific community. Researchers, professionals, and students alike can benefit from the rich repository of knowledge that Natural Products and Bioprospecting continuously curates and disseminates, making it an invaluable resource in the quest for innovative solutions derived from nature.

International Journal of Peptide Research and Therapeutics, published by Springer, is a distinguished platform that bridges the gap between peptide research, therapeutic applications, and interdisciplinary sciences. With a focus on providing high-quality research, this journal covers a broad array of topics including analytical chemistry, biochemistry, drug discovery, and bioengineering, reflecting the essential role peptides play in modern medicine and biotechnology. The journal holds a respectable Q3 quartile ranking across its relevant fields as of 2023, underscoring its position as a noteworthy contributor to ongoing discussions in peptide science. Operating under an Open Access model, it aims to enhance the dissemination of knowledge and foster collaborative research efforts globally. Since its inception in 1996, the journal has evolved through various converged years to continue attracting submissions that push the boundaries of peptide research and its therapeutic potential. Researchers, professionals, and students are encouraged to engage with this journal to explore cutting-edge findings and contribute to the advancing field of peptide science.

JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY, published by Taylor & Francis Ltd, is a premier open-access journal that has been at the forefront of research in the field of medicinal chemistry since its inception in 1985. With an ISSN of 1475-6366 and an E-ISSN of 1475-6374, this journal boasts a prestigious reputation reflected in its impressive Q1 rankings across critical categories such as Drug Discovery and Pharmacology as of 2023. Situated in the United Kingdom, it plays a vital role in disseminating high-quality research that addresses the burgeoning needs of drug discovery and enzyme inhibition methodologies. The journal supports full open access, providing a platform for researchers, professionals, and students to share significant findings and innovations widely. With a robust impact factor, the JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY is indispensable for any academic or professional involved in the pharmacological sciences, offering an unparalleled insight into the latest advancements in therapeutic strategies and drug development.

CURRENT TOPICS IN MEDICINAL CHEMISTRY is a prestigious journal published by Bentham Science Publishers Ltd, dedicated to advancing the field of medicinal chemistry through the dissemination of high-quality research from 2001 to 2024. With an ISSN of 1568-0266 and an E-ISSN of 1873-4294, this journal is recognized for its significant contributions, as evidenced by its Scopus ranking in the 63rd percentile in the category of Drug Discovery, specifically at position #58 out of 157. Currently placed in Quartile 3 within Drug Discovery and Quartile 2 in miscellaneous medicine as of 2023, it serves as an essential resource for researchers, professionals, and students interested in the latest developments, methodologies, and applications in medicinal chemistry. The journal aims to foster collaboration and innovation by featuring original research articles, reviews, and brief communications that address current and emerging challenges in the discipline. Although it is not an open access platform, the journal's rich content is indispensable for those striving to enhance therapeutic strategies and drug development processes.

Boletin Latinoamericano y del Caribe de Plantas Medicinales y Aromaticas, published by MS-EDITIONS, serves as a vital platform for the dissemination of research and insights related to medicinal and aromatic plants in Latin America and the Caribbean. With its ISSN 0717-7917, this journal operates within multiple scientific categories, achieving notable rankings, including Q3 in Complementary and Alternative Medicine and Q4 in Drug Discovery, Pharmacology, and Plant Science for 2023. The journal is committed to providing a space for high-quality research that supports the exploration of traditional and innovative uses of plant resources in health and wellness. Researchers, professionals, and students are encouraged to contribute their findings from 2008 through 2024, fostering a rich collaborative environment that advances knowledge in this essential field. Though not officially listed as open access, Boletin Latinoamericano y del Caribe de Plantas Medicinales y Aromaticas remains a critical resource for those invested in the science of plant-based therapies and their implications in modern medicine.

Current Computer-Aided Drug Design, published by BENTHAM SCIENCE PUBL LTD, is a pivotal journal dedicated to the integration of computer-aided methodologies within the drug design process. With its ISSN 1573-4099 and E-ISSN 1875-6697, this journal serves as a vital resource for researchers, professionals, and students interested in advancing the fields of pharmacology and molecular medicine. Operating under a framework that spans from 2006 to 2024, it aims to foster innovative approaches and discussions surrounding drug design strategies, computational techniques, and the therapeutic potential of novel compounds. Although it currently holds a Q4 rating in Drug Discovery and Molecular Medicine as well as a Q3 in Medicine (miscellaneous) within the 2023 category quartiles, the journal continues to enhance its visibility and relevance in the academic community. Its Scopus rankings reflect its commitment to quality research, positioning it in the context of drug discovery and molecular studies. As the field of drug design evolves, Current Computer-Aided Drug Design remains an essential platform for disseminating cutting-edge findings and facilitating collaboration among specialists aiming for significant advancements in drug development.

Natural Products Journal, a leading publication by Bentham Science Publishers, primarily focuses on the rapidly evolving field of Natural Products and their applications in Complementary and Alternative Medicine as well as Drug Discovery. With an ISSN of 2210-3155 and an E-ISSN of 2210-3163, this journal serves as an essential platform for researchers, professionals, and students dedicated to exploring the critical role of natural compounds in health and medicine. Since its inception in 2011, it has consolidated its reputation, achieving a Q3 ranking in Complementary and Alternative Medicine and a Q4 ranking in Drug Discovery as of 2023, illustrating its growing influence within the academic community. Although it currently does not operate as an Open Access journal, it remains a vital resource for cutting-edge research and developments in natural products, offering insightful contributions that pave the way for innovative therapeutic strategies. Located in the Netherlands, the journal is pivotal for those looking to stay at the forefront of research in natural substances and their multifaceted applications.

Fitoterapia is a prestigious journal published by Elsevier that specializes in the fields of drug discovery and pharmacology. Established in 1948 and featuring a comprehensive scope that encompasses all aspects of medicinal plants and their derivatives, this journal is a critical resource for researchers, professionals, and students interested in the pharmacological effects of natural products. With an impressive impact factor reflected in its Q2 ranking in both Drug Discovery and Medicine as well as a Q3 ranking in Pharmacology, Fitoterapia plays a vital role in promoting innovative research in the intersection of traditional medicine and modern pharmacological science. The journal’s commitment to quality is further highlighted by its rankings in Scopus, where it holds a notable position among peers in its field. Although Fitoterapia does not currently offer Open Access, its reputation for rigor and relevance makes it an indispensable asset for anyone engaged in herbal medicine research and development. Authors and researchers seeking to publish groundbreaking findings will find a welcoming platform to disseminate their work in this influential journal.